Kupando
PrivateLast Round
Series A
Extension
Mar 18, 2026
Total Funding Raised
$24.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kupando is a biopharmaceutical company developing small-molecule immunotherapies that stimulate the innate immune system to address unmet needs in oncology and infectious diseases.
Sector
Consumer & Commerce
Verticals
E-commerce, Supply Chain, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kupando Comparables
Compare Kupando with similar companies based on industry and business-model similarity.
No public comparables are available for Kupando. Request access to learn about comparables coverage.
Request accessKupando Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 18, 2026 | ||||
| Series A | Sep 26, 2022 |
Kupando Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A Extension |
| LifeCare Partners | Series A Extension, Series A |
| Remiges Ventures | Series A Extension, Series A |
| Brandenburg Kapital | Series A Extension, Series A |
| Ventura BioMed Investors | Series A Extension, Series A |
| CARMA FUND | Series A Extension |
| High-Tech Gründerfonds | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$11.5M raised in Series A Extension round.
- Sep 26, 2022
$13M round led by LifeCare Partners and Remiges Ventures.
Kupando Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kupando's valuation, stock price, and market status.
Is Kupando a public or private company?
Kupando is a private company.
What is the current stock price of Kupando?
Kupando is a private company with no public stock price. No recent secondary market data is available.
How much is Kupando worth (valuation)?
Valuation information for Kupando is not publicly available.
Can I buy Kupando stock?
Kupando shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kupando's last funding round?
Kupando's most recent funding round was Series A Extension on March 18, 2026.
Who are the main investors in Kupando?
Key investors in Kupando include LifeCare Partners, Remiges Ventures.
Will Kupando IPO soon?
No public IPO plans have been announced for Kupando.
How can I track Kupando secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kupando's secondary market activity and sign up for updates.